Processa receives second 180-day grace period to regain Nasdaq bid price compliance

Processa Pharmaceuticals, Inc.

Grace period runs until February 2, 2026 to meet $1.00 minimum bid price.
Compliance requires closing bid price ≥ $1.00 for 10 consecutive business days.
Company will consider a reverse stock split if needed to cure deficiency.
Common stock continues trading on Nasdaq Capital Market during the period.

item 3.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.